Cytokine modulation of liver annexin 1 expression during experimental endotoxemia.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 1850497)

Published in Am J Pathol on October 01, 2001

Authors

C de Coupade1, M N Ajuebor, F Russo-Marie, M Perretti, E Solito

Author Affiliations

1: Department of Cell Biology, Institut Cochin de Génétique Moléculaire, Paris, France.

Articles citing this

Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol (2008) 1.43

Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol (2005) 1.27

Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: Correlation to clinical pain. Pain (2009) 1.19

Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. J Immunol (2010) 1.19

Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. Am J Pathol (2003) 1.08

Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A (2012) 1.01

Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha. Am J Pathol (2007) 0.96

Annexin-A1 peptide down-regulates the leukocyte recruitment and up-regulates interleukin-10 release into lung after intestinal ischemia-reperfusion in mice. J Inflamm (Lond) (2013) 0.91

Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue. Am J Physiol Endocrinol Metab (2006) 0.87

Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells. PLoS One (2009) 0.83

Proteomic mapping of stimulus-specific signaling pathways involved in THP-1 cells exposed to Porphyromonas gingivalis or its purified components. J Proteome Res (2007) 0.82

Dysregulation of anti-inflammatory annexin A1 expression in progressive Crohns Disease. PLoS One (2013) 0.82

Differential modulatory effects of annexin 1 on nitric oxide synthase induction by lipopolysaccharide in macrophages. Immunology (2006) 0.81

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis. BMC Immunol (2011) 0.81

Targeting neutrophil apoptosis for enhancing the resolution of inflammation. Cells (2013) 0.80

The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis. Mol Vis (2012) 0.77

The hypothesis that Helicobacter pylori predisposes to Alzheimer's disease is biologically plausible. Sci Rep (2017) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25

Phylogenetic perspectives in innate immunity. Science (1999) 9.42

Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science (1986) 9.19

Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63

The acute phase response. Immunol Today (1994) 7.53

Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol (1995) 6.99

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest (1998) 4.77

Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (1980) 4.29

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity (1997) 4.19

Defective inflammatory response in interleukin 6-deficient mice. J Exp Med (1994) 2.92

Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol (1999) 1.99

Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med (1996) 1.96

Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol (1989) 1.93

Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture. J Biol Chem (1989) 1.64

A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell (2000) 1.64

Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A (1998) 1.60

Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J Leukoc Biol (2000) 1.55

Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med (1999) 1.53

Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J Clin Invest (1989) 1.42

Intrapulmonary cytokine accumulation following BAL and the role of endotoxin contamination. Chest (1999) 1.41

The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol (1996) 1.38

NF-IL6 and NF-kappa B in cytokine gene regulation. Adv Immunol (1997) 1.37

Regulation of the acute phase response by cytokines. Perspect Biol Med (1993) 1.33

Lipocortin I (p35) is abundant in a restricted number of differentiated cell types in adult organs. J Cell Physiol (1989) 1.32

Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology (1996) 1.30

Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression. Infect Immun (1991) 1.24

Endogenous mediators that inhibit the leukocyte-endothelium interaction. Trends Pharmacol Sci (1997) 1.24

Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A (1994) 1.23

Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ (1998) 1.20

Endotoxin stimulates hepatocyte interleukin-6 production. J Surg Res (1999) 1.16

Dexamethasone-induced inhibition of prostaglandin production dose not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor. Biochim Biophys Acta (1982) 1.15

IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine (1998) 1.14

Glucocorticoids and stress: permissive and suppressive actions. Ann N Y Acad Sci (1994) 1.14

Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation. Br J Pharmacol (1996) 1.11

Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology (2000) 1.10

Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells. FEBS Lett (1989) 1.05

Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol (1999) 1.03

Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis. Infect Immun (1999) 1.02

Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. J Immunol (2000) 1.02

Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol (1995) 1.02

Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits. Exp Eye Res (1999) 1.01

Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol (2001) 1.00

Delineation of the proinflammatory cytokine cascade in fever induction. Ann N Y Acad Sci (1998) 0.99

The acute phase protein response during parasitic infection. Immunol Today (1991) 0.97

U937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity. Br J Pharmacol (1998) 0.95

Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1. Br J Pharmacol (1996) 0.94

Serum corticosterone, interleukin-1 and tumour necrosis factor in rat experimental endotoxaemia: comparison between Lewis and Wistar strains. Br J Pharmacol (1993) 0.89

How bacteria initiate inflammation: aspects of the emerging story. Curr Opin Microbiol (1998) 0.89

Differential modulation of annexin I binding sites on monocytes and neutrophils. Mediators Inflamm (1999) 0.88

Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. J Clin Invest (1996) 0.87

Modulation of glucocorticoid receptor expression in human bronchial epithelial cell lines by IL-1 beta, TNF-alpha and LPS. Eur Respir J (1996) 0.87

Hematopoietic growth factors and glucocorticoids synergize to mimic the effects of IL-1 on granulocyte differentiation and IL-1 receptor induction on bone marrow cells in vivo. Exp Hematol (1993) 0.87

Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6-deficient mice. Cytokine (1997) 0.86

The role of lipocortin-1 in dexamethasone-induced suppression of PGE2 and TNF alpha release from human peripheral blood mononuclear cells. Br J Pharmacol (1996) 0.83

Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes. Mediators Inflamm (2000) 0.82

Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins. Biochem J (1998) 0.80

Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor. Thromb Haemost (1997) 0.79

Articles by these authors

Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol (1999) 1.99

Anti-phospholipase proteins. Prostaglandins (1984) 1.93

The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat Struct Biol (1999) 1.72

Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A (1998) 1.60

The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils. J Exp Med (2001) 1.59

Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br J Pharmacol (1997) 1.50

Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J Leukoc Biol (1998) 1.49

Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med (1997) 1.47

Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol (2008) 1.43

Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J Clin Invest (1989) 1.42

Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med (2001) 1.41

Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br J Pharmacol (1993) 1.40

Characterization and partial purification of 'renocortins': two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids. Br J Pharmacol (1983) 1.39

Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am J Pathol (2001) 1.37

Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am J Pathol (2001) 1.35

Structural basis of the Ca(2+)-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I. Structure (2000) 1.34

Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J Immunol (1995) 1.30

A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin. Anal Biochem (1989) 1.28

Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci U S A (1995) 1.24

Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A (1994) 1.23

Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res (2001) 1.22

POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol (1999) 1.20

Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ (1998) 1.20

Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J (2001) 1.16

Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol (1997) 1.15

Dexamethasone-induced inhibition of prostaglandin production dose not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor. Biochim Biophys Acta (1982) 1.15

IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine (1998) 1.14

Association between kinin B(1) receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules. J Exp Med (2000) 1.13

Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents Actions (1992) 1.13

Involvement of glucocorticoid receptors in steroid-induced inhibition of prostaglandin secretion. J Biol Chem (1979) 1.12

Defective IFN-gamma production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E. J Immunol (1985) 1.12

Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice. Arthritis Rheum (2002) 1.12

A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br J Pharmacol (1989) 1.11

Platelet activation--a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin. Nature (1986) 1.11

Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol (1985) (1993) 1.11

Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent. FEBS Lett (1987) 1.10

Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology (2000) 1.10

Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration. J Immunol (1997) 1.09

Further characterization of the glucocorticoid-induced antiphospholipase protein "renocortin". Biochem Biophys Res Commun (1983) 1.08

Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and annexin 1. Clin Exp Immunol (2001) 1.07

Involvement of bradykinin B1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1 beta in vivo in the mouse. J Immunol (1996) 1.06

Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins. J Pharmacol Exp Ther (1997) 1.05

21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. Br J Pharmacol (2000) 1.04

Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation. Inflamm Res (1998) 1.04

Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: role of intercellular adhesion molecule 1 and KC. Gut (1999) 1.04

Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. J Immunol (2000) 1.02

The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids. Biochim Biophys Acta (1985) 1.01

Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol (2001) 1.00

An immunocytochemical and in situ hybridization analysis of annexin 1 expression in rat mast cells: modulation by inflammation and dexamethasone. Lab Invest (2000) 1.00

Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. FASEB J (2000) 1.00

Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition. J Biol Chem (1997) 1.00

Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther (2006) 0.99

Purification and characterization of a 32-kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cells. FEBS Lett (1987) 0.98

The annexin-1 knockout mouse: what it tells us about the inflammatory response. J Physiol Pharmacol (2002) 0.97

Glucocorticoid-induced annexin 1 secretion by monocytes and peritoneal leukocytes. Br J Pharmacol (1995) 0.96

B1 receptors as a new inflammatory target. Could this B the 1? Trends Pharmacol Sci (1999) 0.96

A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment. Br J Pharmacol (1997) 0.96

Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig. Biochem Biophys Res Commun (1985) 0.96

The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. Br J Pharmacol (2010) 0.96

Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation. Immunology (1998) 0.96

U937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity. Br J Pharmacol (1998) 0.95

Kinin B(1) receptors and the cardiovascular system: regulation of expression and function. Cardiovasc Res (2000) 0.95

Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration. Biochem J (1998) 0.95

Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J Leukoc Biol (2001) 0.95

Inducible expression of the kinin B1 receptor in the endotoxemic heart: mechanisms of des-Arg9bradykinin-induced coronary vasodilation. Br J Pharmacol (1999) 0.94

Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br J Pharmacol (1999) 0.94

Effect of interleukin-1 beta on the release of substance P from rat isolated spinal cord. Eur J Pharmacol (1996) 0.94

Inflammation-induced modulation of cellular galectin-1 and -3 expression in a model of rat peritonitis. Inflamm Res (2006) 0.93

Dexamethasone inhibits cytokine-induced intercellular adhesion molecule-1 up-regulation on endothelial cell lines. Eur J Pharmacol (1997) 0.93

Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1. Br J Pharmacol (1993) 0.93

Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates. Eur J Biochem (1995) 0.93

In adrenocortical tissue, annexins II and VI are attached to clathrin coated vesicles in a calcium-independent manner. Biochim Biophys Acta (1998) 0.92

Relative contribution of the selectins in the neutrophil recruitment caused by the chemokine cytokine-induced neutrophil chemoattractant (CINC). Biochem Biophys Res Commun (1996) 0.92

Differential effects of sex steroids on prostaglandin secretion by male and female cultured piglet endothelial cells. Prostaglandins (1983) 0.92

Investigation of the functional role played by the chemokine monocyte chemoattractant protein-1 in interleukin-1-induced murine peritonitis. Br J Pharmacol (1998) 0.91

Glucocorticoid receptor activation reduces CD11b and CD49d levels on murine eosinophils: characterization and functional relevance. Am J Respir Cell Mol Biol (2000) 0.90

Identification and characterization of phospholipase A2 inhibitory proteins in human mononuclear cells. Eur J Biochem (1990) 0.90

Annexins and protein kinases C. Biochim Biophys Acta (1996) 0.90

Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'. Biochim Biophys Acta (1988) 0.89

Fluctuation of annexin-A1 positive mast cells in chronic granulomatous inflammation. Inflamm Res (2008) 0.89

Annexin 1 and neutrophil apoptosis. Biochem Soc Trans (2004) 0.89

A novel anti-inflammatory peptide from human lipocortin 5. Br J Pharmacol (1991) 0.89

The annexins: structure and functions. Cell Calcium (2000) 0.89

An annexin 1 (ANXA1)-derived peptide inhibits prototype antigen-driven human T cell Th1 and Th2 responses in vitro. Clin Exp Allergy (2001) 0.89

Subacute treatment of rats with dexamethasone reduces ICAM-1 levels on circulating monocytes. Biochem Biophys Res Commun (1997) 0.88

Differential modulation of annexin I binding sites on monocytes and neutrophils. Mediators Inflamm (1999) 0.88

Mechanism of reaction of melatonin with human myeloperoxidase. Biochem Biophys Res Commun (2001) 0.88

Upregulation of ICAM-1 expression on J774.2 macrophages by endotoxin involves activation of NF-kappaB but not protein tyrosine kinase: comparison to induction of iNOS. Mediators Inflamm (1999) 0.88

The role of lipocortin-1 in the inhibitory action of dexamethasone on eosinophil trafficking in cutaneous inflammatory reactions in the mouse. Br J Pharmacol (1998) 0.88

Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides. FASEB J (2007) 0.88

Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem Biophys Res Commun (1999) 0.88

Are the lipocortins the second messengers of the anti-inflammatory action of glucocorticoids? Prog Clin Biol Res (1990) 0.88

A twist in anti-inflammation: annexin 1 acts via the lipoxin A4 receptor. Prostaglandins Leukot Essent Fatty Acids (2005) 0.88